Back to home

Consent for e-Marketing communications from Orion Pharma (UK) LTD.

07/07/2020

We would like to process your contact details to allow us to send you information about our products and services which may be of interest. This information could be of a promotional or educational nature. You may withdraw your consent to direct marketing at any time by clicking through the link in any of the communications that you receive. Please note that withdrawal of your consent will not render the processing of your information prior to the withdrawal unlawful.


To receive further information on how we process your personal data, please read our information Notice http://orionpharma.co.uk/policies/information-notices/ .

EPERMISSIONS

Yes, I would like to receive scientific, educational and promotional content from Orion Corporation and its affiliates by:
By submitting your personal details, you give your consent to Orion Corporation and its affiliates (see list here) to process your personal data for the purposes of electronic direct marketing.
 
To receive further information on how we process your personal data, please read more here. You may withdraw your consent at any time by clicking the link in any of the communications you receive. Please note that withdrawal of your consent will not render the processing of your information prior to the withdrawal unlawful. 
 
*Required information to process this request.
 
October 2020 / CORP-228.

ORIONPHARMA.CO.UK

 

Full prescribing information available here

 

JANUARY 2021 / RESP-765(1)

 

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Orion Pharma (UK) Ltd on 01635 520300.

Orion Pharma (UK) Ltd, Oaklea Court, 22 Park Street, Newbury, Berkshire RG14 1EA UK | Tel: +44 1635 520 300 Date of Preparation: October 2019 / RESP-330
Policies Contact us Orion Corporation 2021